Genmab A/S

Director, Real World Data & Epidemiology (RWD & EPI) Analytics

Genmab A/S$231K — $346K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • PhD or Masters in Epidemiology, Biostatistics, Public Health, or related field.
  • Over 10 years of experience in real-world evidence generation and epidemiology analytics.
  • Strong expertise in observational study design and statistical methods (including survival analysis, regression analysis).
  • Proficient in statistical programming languages such as SAS, R, and Python, especially for real-world claims/EHR data.
  • Experience with AI/ML frameworks and substantial oncology knowledge preferred.

Responsibilities

  • Design and execute observational and epidemiologic studies in collaboration with CORE asset leaders.
  • Conduct feasibility analyses to identify suitable RWD sources for various studies.
  • Manage the entirety of studies, ensuring adherence to standards in data handling and analysis.
  • Translate complex study findings into actionable insights for diverse audiences.
  • Evaluate and integrate new data modalities into the research framework.
  • Lead the development and implementation of AI applications in routine analytics.
  • Define processes and standards for data management and study execution.

Benefits

  • 401(k) with 100% match on first 6% contributions.
  • Comprehensive health benefits including two medical plans, dental, and vision insurance.
  • Paid vacation, sick leave, and 12 weeks of paid parental leave.
  • Access to backup care and financial wellness tools.
  • Commuter benefits, tuition reimbursement, and wellness expense allowances.
Full Job Description
Role

The Director of Real-World Data & Epidemiology (RWD & Epi) Analytics will lead the design, execute, and communicate observational studies using diverse RWD sources. This role combines strategic leadership, deep technical expertise in observational study design and execution, data and analytic infrastructure development, and advanced AI-driven analytics to deliver evidence that informs clinical development, market access, and health-policy decisions. This position reports to Head of RWD & Epi analytics at Center for Outcomes Research, Real World Evidence and Epidemiology (CORE).

Responsibilities

Collaborate with CORE asset leaders to design, execute, and report on observational and epidemiologic studies in support of assigned assets and indications-from feasibility analyses and protocol development, RWE/Epi methods advice, to data analysis and final reporting.
  • Conduct feasibility assessments to match study objectives with optimal RWD sources (claims, EHR, registries, patient-generated data).
  • Collaborate with CORE asset leaders to conduct survival and economic modeling to support HTA activities.
  • Execute studies by managing table shells, analytic data file, analysis plan, programming, statistical methods, and quality control per regulatory and scientific standards.
  • Present study designs, interim analyses, and final results to study team, translating complex findings into actionable insights for both technical and non-technical audiences.
  • Evaluate new and emerging data modalities (e.g., claims, EHR, social determinants of health, genomics, biomarkers, clinical notes) for study applicability and integrate them into the evidence-generation framework.
  • Lead pilots and scale successful AI applications in routine RWD & Epi analytics.
  • Partner with CORE asset leaders to define evidence needs, set realistic timelines, and manage expectations.
  • Mentor and coach RWD & Epi scientists and programmers -fostering technical growth in study methods, programming skills, and critical thinking.
  • Define and implement standardized processes and governance for study execution, data management, and documentation within the analytic environment.
  • Evolve and scale the data and analytics infrastructure-partnering with DD&AI to streamline pipelines, ensure reproducibility, and maintain data security and compliance.
  • As a member of the CORE team, contribute to department strategy and objectives as well as represent CORE on key initiatives


Requirements
  • Graduate (PhD or Masters) degree in Epidemiology, Biostatistics, Public Health, or related field.
  • 10+ years' experience in real-world evidence generation and epidemiology analytics.
  • Demonstrated expertise in observational study design, statistical methods (survival analysis/modeling, regression analysis, IPTW, MAIC, causal inference, etc), and RWD evaluation.
  • Hands-on proficiency in statistical programming (SAS, R, Python) on real-world claims/EHR data and AI/ML frameworks.
  • Exceptional communication, presentation, and stakeholder-management skills.
  • Oncology experience preferred
  • Strong commercial and clinical strategic mindset.
  • Demonstrated research accomplishments as evidenced by a history of peer-reviewed publications.
  • Ability to work well in a team and cross-functional environment, as well as work independently with limited supervision.
  • Ability to work successfully under pressure in a fast-paced environment and with tight timelines
  • Ability to be proactive, enthusiastic and goal orientated
  • Strong communication skills - both oral and written
  • Work arrangement: This role offers flexibility to work away from the office for 20%-40% of a typical schedule. Employees may use this work schedule in increments of single days or multiple consecutive days, provided it does not exceed 40% within a 60-day period, and is approved by the hiring manager.


For US based candidates, the proposed salary band for this position is as follows:

$231,280.00---$346,920.00

The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives.

When you join Genmab, you're joining a culture that supports your physical, financial, social, and emotional wellness. Within the first year, regular full-time U.S. employees are eligible for:
  • 401(k) Plan: 100% match on the first 6% of contributions
  • Health Benefits: Two medical plan options (including HDHP with HSA), dental, and vision insurance
  • Voluntary Plans: Critical illness, accident, and hospital indemnity insurance
  • Time Off: Paid vacation, sick leave, holidays, and 12 weeks of discretionary paid parental leave
  • Support Resources: Access to child and adult backup care, family support programs, financial wellness tools, and emotional well-being support
  • Additional Perks: Commuter benefits, tuition reimbursement, and a Lifestyle Spending Account for wellness and personal expenses


Further details on eligibility for compensation and benefits based on role will be provided during the recruitment process

Please note that if you are applying for a position in the Netherlands, Genmab's policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.

About Genmab A/S

Genmab A/S is a Denmark-based international biotechnology company. It specializes in the creation and development of differentiated human antibody therapeutics for the treatment of cancer. The Company's product pipeline includes Darzalex (daratumumab), which is in Phase III clinical development for the treatment of multiple myeloma; MOR208, which is in Phase IIa clinical development for the treatment of non-Hodgkin's lymphoma, and MOR202, which is in Phase II clinical development for the treatment of multiple myeloma. The Company has collaborations with pharmaceutical and biotechnology companies and research institutions. Its partners include Janssen Biotech, Inc., Novo Nordisk A/S, Seagen Inc., BioNTech AG, Immatics Biotechnologies GmbH, and Bolt Biotherapeutics, Inc., among others.
Learn more about Genmab A/S
Size
1,309 employees
Market Cap
$27.9 billion
Industry
Net Income
$5.6 billion
Founded
1999
Revenue
$11 billion
NASDAQ

Similar Jobs

More Jobs at Genmab A/S

More Pharmaceuticals & Biotech Jobs

Find similar Director, Real World Data & Epidemiology (RWD & EPI) Analytics jobs: